Interstitial lung disease: The initial approach

Medical Clinics of North America

Volumn 95, Issue 6, 2011, Pages 1071-1093

  Alhamad, Esam H ^a   Cosgrove, Gregory P ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

Gastroesophageal reflux disease; High resolution computed tomography; Idiopathic pulmonary fibrosis; Pulmonary hypertension

Indexed keywords

ALLERGIC PNEUMONITIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CIGARETTE SMOKING; CLINICAL FEATURE; COMORBIDITY; CONNECTIVE TISSUE DISEASE; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; HIGH RESOLUTION COMPUTER TOMOGRAPHY; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SARCOIDOSIS; SLEEP DISORDERED BREATHING;

BRONCHIECTASIS; BRONCHOSCOPY; CONNECTIVE TISSUE DISEASES; DIAGNOSIS, DIFFERENTIAL; ENVIRONMENTAL EXPOSURE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MEDICAL HISTORY TAKING; OCCUPATIONAL EXPOSURE; PHYSICAL EXAMINATION; SARCOIDOSIS, PULMONARY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 82455172277     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2011.08.008     Document Type: Review

References (111)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002, 165(2):277-304.
2. Craig P.J., Wells A.U., Doffman S., et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004, 45(3):275-282.
3. Ryu J.H., Myers J.L., Capizzi S.A., et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005, 127(1):178-184.
4. Raghu G., Collard H.R., Egan J.J., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183(6):788-824.
5. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999, 160(2):736-755.
6. Alhamad E.H., Alanezi M.O., Idrees M.M., et al. Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis. Ann Saudi Med 2009, 29(6):454-459.
7. Keane M.P., Lynch J.P. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000, 55(2):159-166.
8. Lee D.M., Weinblatt M.E. Rheumatoid arthritis. Lancet 2001, 358(9285):903-911.
9. Steen V.D., Medsger T.A. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000, 43(11):2437-2444.
10. Gribbin J., Hubbard R.B., Le Jeune I., et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006, 61(11):980-985.
11. Raghu G., Weycker D., Edelsberg J., et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174(7):810-816.
12. Ryu J.H., Moss J., Beck G.J., et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2006, 173(1):105-111.
13. Alhamad E.H. Familial interstitial lung disease in four members of one family: a case series. Cases J 2009, 2:9356.
14. Garcia C.K., Raghu G. Inherited interstitial lung disease. Clin Chest Med 2004, 25(3):421-433. v.
15. Flieder D.B., Travis W.D. Pathologic characteristics of drug-induced lung disease. Clin Chest Med 2004, 25(1):37-45.
16. Walker T., McCaffery J., Steinfort C. Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease. Med J Aust. Jan 15 2007, 186(2):91-94.
17. Wolff A.J., O'Donnell A.E. Pulmonary effects of illicit drug use. Clin Chest Med 2004, 25(1):203-216.
18. Glazer C.S., Newman L.S. Occupational interstitial lung disease. Clin Chest Med 2004, 25(3):467-478. vi.
19. Baumgartner K.B., Samet J.M., Coultas D.B., et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. Am J Epidemiol 2000, 152(4):307-315.
20. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000, 161(2 Pt 1):646-664.
21. Avouac J., Airo P., Meune C., et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010, 37(11):2290-2298.
22. Johnson S.R., Gladman D.D., Urowitz M.B., et al. Pulmonary hypertension in systemic lupus. Lupus 2004, 13(7):506-509.
23. Todd N.W., Lavania S., Park M.H., et al. Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia. J Heart Lung Transplant 2010, 29(2):188-194.
24. Udayakumar N., Venkatesan S., Rajendiran C. Pulmonary hypertension in rheumatoid arthritis-relation with the duration of the disease. Int J Cardiol 2008, 127(3):410-412.
25. Wigley F.M., Lima J.A., Mayes M., et al. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum 2005, 52(7):2125-2132.
26. Handa T., Nagai S., Miki S., et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 2006, 129(5):1246-1252.
27. Alhamad E.H., Idrees M.M., Alanezi M.O., et al. Sarcoidosis-associated pulmonary hypertension: clinical features and outcomes in Arab patients. Ann Thorac Med 2010, 5(2):86-91.
28. Shorr A.F., Helman D.L., Davies D.B., et al. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005, 25(5):783-788.
29. Shorr A.F., Wainright J.L., Cors C.S., et al. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007, 30(4):715-721.
30. Lettieri C.J., Nathan S.D., Barnett S.D., et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006, 129(3):746-752.
31. McLaughlin V.V., Archer S.L., Badesch D.B., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009, 53(17):1573-1619.
32. Fischer A., West S.G., Swigris J.J., et al. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010, 138(2):251-256.
33. Hebert J., Beaudoin J., Laviolette M., et al. Absence of correlation between the degree of alveolitis and antibody levels to Micropolysporum faeni. Clin Exp Immunol 1985, 60(3):572-578.
34. Pinon J.M., Geers R., Lepan H., et al. Immunodetection by enzyme-linked immuno-filtration assay (ELIFA) of IgG, IgM, IgA and IgE antibodies in bird breeder's disease. Eur J Respir Dis 1987, 71(3):164-169.
35. Ohtani Y., Saiki S., Sumi Y., et al. Clinical features of recurrent and insidious chronic bird fancier's lung. Ann Allergy Asthma Immunol 2003, 90(6):604-610.
36. Lacasse Y., Selman M., Costabel U., et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003, 168(8):952-958.
37. Alhamad E.H., Lynch J.P., Martinez F.J. Pulmonary function tests in interstitial lung disease: what role do they have?. Clin Chest Med 2001, 22(4):715-750. ix.
38. Kawut S.M., O'Shea M.K., Bartels M.N., et al. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med 2005, 99(11):1431-1439.
39. Flaherty K.R., Andrei A.C., Murray S., et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006, 174(7):803-809.
40. Baughman R.P., Sparkman B.K., Lower E.E. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007, 132(1):207-213.
41. Alhamad E.H. The six-minute walk test in patients with pulmonary sarcoidosis. Ann Thorac Med 2009, 4(2):60-64.
42. Alhamad E.H., Shaik S.A., Idrees M.M., et al. Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis. BMC Pulm Med 2010, 10:42.
43. Schoindre Y., Meune C., Dinh-Xuan A.T., et al. Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis. J Rheumatol 2009, 36(7):1481-1485.
44. Epler G.R., McLoud T.C., Gaensler E.A., et al. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978, 298(17):934-939.
45. Gaensler E.A., Carrington C.B. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg 1980, 30(5):411-426.
46. Ryu J.H., Olson E.J., Midthun D.E., et al. Diagnostic approach to the patient with diffuse lung disease. Mayo Clin Proc 2002, 77(11):1221-1227. quiz 1227.
47. Koyama M., Johkoh T., Honda O., et al. Chronic cystic lung disease: diagnostic accuracy of high-resolution CT in 92 patients. AJR Am J Roentgenol 2003, 180(3):827-835.
48. Johkoh T., Muller N.L., Cartier Y., et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999, 211(2):555-560.
49. Hunninghake G.W., Zimmerman M.B., Schwartz D.A., et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. Jul 15 2001, 164(2):193-196.
50. Flaherty K.R., Thwaite E.L., Kazerooni E.A., et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003, 58(2):143-148.
51. Sundaram B., Gross B.H., Martinez F.J., et al. Accuracy of high-resolution CT in the diagnosis of diffuse lung disease: effect of predominance and distribution of findings. AJR Am J Roentgenol 2008, 191(4):1032-1039.
52. Primack S.L., Hartman T.E., Hansell D.M., et al. End-stage lung disease: CT findings in 61 patients. Radiology 1993, 189(3):681-686.
53. Silva C.I., Muller N.L., Lynch D.A., et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008, 246(1):288-297.
54. Bensard D.D., McIntyre R.C., Waring B.J., et al. Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. Chest 1993, 103(3):765-770.
55. Tiitto L., Heiskanen U., Bloigu R., et al. Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia. Chest 2005, 128(4):2375-2380.
56. Kondoh Y., Taniguchi H., Kitaichi M., et al. Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Respir Med 2006, 100(10):1753-1759.
57. Park I.N., Kim D.S., Shim T.S., et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007, 132(1):214-220.
58. Flaherty K.R., Travis W.D., Colby T.V., et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001, 164(9):1722-1727.
59. Monaghan H., Wells A.U., Colby T.V., et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004, 125(2):522-526.
60. Antoniou K.M., Margaritopoulos G., Economidou F., et al. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J 2009, 33(4):882-896.
61. Flaherty K.R., Andrei A.C., King T.E., et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?. Am J Respir Crit Care Med 2007, 175(10):1054-1060.
62. Flaherty K.R., King T.E., Raghu G., et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 2004, 170(8):904-910.
63. Castelino F.V., Goldberg H., Dellaripa P.F. The impact of rheumatological evaluation in the management of patients with interstitial lung disease. Rheumatology (Oxford) 2011, 50(3):489-493.
64. Mays E.E., Dubois J.J., Hamilton G.B. Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 1976, 69(4):512-515.
65. Piesman M., Hwang I., Maydonovitch C., et al. Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter?. Am J Gastroenterol 2007, 102(10):2128-2134.
66. Raghu G., Freudenberger T.D., Yang S., et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006, 27(1):136-142.
67. Savarino E., Bazzica M., Zentilin P., et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 2009, 179(5):408-413.
68. Tcherakian C., Cottin V., Brillet P.Y., et al. Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease. Thorax 2011, 66(3):226-231.
69. Kondoh Y., Taniguchi H., Kawabata Y., et al. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 1993, 103(6):1808-1812.
70. Akira M., Hamada H., Sakatani M., et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 1997, 168(1):79-83.
71. Kim D.S., Park J.H., Park B.K., et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006, 27(1):143-150.
72. Martinez F.J., Safrin S., Weycker D., et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005, 142(12 Pt 1):963-967.
73. Azuma A., Nukiwa T., Tsuboi E., et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005, 171(9):1040-1047.
74. Miyazaki Y., Tateishi T., Akashi T., et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 2008, 134(6):1265-1270.
75. Olson A.L., Huie T.J., Groshong S.D., et al. Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series. Chest 2008, 134(4):844-850.
76. Lederer D.J., Caplan-Shaw C.E., O'Shea M.K., et al. Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis. Am J Transplant 2006, 6(2):398-403.
77. Launay D., Humbert M., Berezne A., et al. Clinical characteristics and survival in systemic sclerosis-related PH associated With ILD. Chest 2011, [Epub ahead of print].
78. Le Pavec J., Girgis R.E., Lechtzin N., et al. Systemic sclerosis related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. Arthritis Rheum 2011, 63(8):2456-2464.
79. Mathai S.C., Hummers L.K., Champion H.C., et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 2009, 60(2):569-577.
80. Condliffe R., Kiely D.G., Peacock A.J., et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009, 179(2):151-157.
81. Behr J., Ryu J.H. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008, 31(6):1357-1367.
82. Patel N.M., Lederer D.J., Borczuk A.C., et al. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007, 132(3):998-1006.
83. Polomis D., Runo J.R., Meyer K.C. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med 2008, 14(5):462-469.
84. Fisher M.R., Forfia P.R., Chamera E., et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009, 179(7):615-621.
85. Arcasoy S.M., Christie J.D., Ferrari V.A., et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003, 167(5):735-740.
86. Zisman D.A., Karlamangla A.S., Ross D.J., et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007, 132(3):773-779.
87. Devaraj A., Wells A.U., Meister M.G., et al. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008, 249(3):1042-1049.
88. Alhamad E.H., Al-Boukai A.A., Al-Kassimi F.A., et al. Prediction of pulmonary hypertension in patients with or without interstitial lung disease: reliability of CT findings. Radiology 2011, 260(3):875-883.
89. Chang B., Wigley F.M., White B., et al. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 2003, 30(11):2398-2405.
90. Leuchte H.H., Neurohr C., Baumgartner R., et al. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 2004, 170(4):360-365.
91. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002, 105(11):1387-1393.
92. Hoeper M.M., Barbera J.A., Channick R.N., et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol 2009, 54(Suppl 1):S85-S96.
93. Zisman D.A., Schwarz M., Anstrom K.J., et al. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 2010, 363(7):620-628.
94. King T.E., Brown K.K., Raghu G., et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011, 184(1):92-99.
95. Bye P.T., Issa F., Berthon-Jones M., et al. Studies of oxygenation during sleep in patients with interstitial lung disease. Am Rev Respir Dis 1984, 129(1):27-32.
96. Perez-Padilla R., West P., Lertzman M., et al. Breathing during sleep in patients with interstitial lung disease. Am Rev Respir Dis 1985, 132(2):224-229.
97. McNicholas W.T., Coffey M., Fitzgerald M.X. Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax 1986, 41(10):777-782.
98. Mermigkis C., Chapman J., Golish J., et al. Sleep-related breathing disorders in patients with idiopathic pulmonary fibrosis. Lung 2007, 185(3):173-178.
99. Mermigkis C., Stagaki E., Tryfon S., et al. How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?. Sleep Breath 2010, 14(4):387-390.
100. Lancaster L.H., Mason W.R., Parnell J.A., et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 2009, 136(3):772-778.
101. Turner G.A., Lower E.E., Corser B.C., et al. Sleep apnea in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1997, 14(1):61-64.
102. Verbraecken J., Hoitsma E., van der Grinten C.P., et al. Sleep disturbances associated with periodic leg movements in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004, 21(2):137-146.
103. Krishnan V., McCormack M.C., Mathai S.C., et al. Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis. Chest 2008, 134(4):693-698.
104. Bouros D., Hatzakis K., Labrakis H., et al. Association of malignancy with diseases causing interstitial pulmonary changes. Chest 2002, 121(4):1278-1289.
105. Park J., Kim D.S., Shim T.S., et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 2001, 17(6):1216-1219.
106. Aubry M.C., Myers J.L., Douglas W.W., et al. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. Mayo Clin Proc 2002, 77(8):763-770.
107. Le Jeune I., Gribbin J., West J., et al. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 2007, 101(12):2534-2540.
108. Fox R.I. Sjogren's syndrome. Lancet 2005, 366(9482):321-331.
109. Brincker H., Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer 1974, 29(3):247-251.
110. Kumar P., Goldstraw P., Yamada K., et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 2003, 125(6):1321-1327.
111. Watanabe A., Higami T., Ohori S., et al. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?. J Thorac Cardiovasc Surg 2008, 136(5):1357-1363. 1363, e1351-2.